Literature DB >> 28884364

A new chemical complex can rapidly concentrate lentivirus and significantly enhance gene transduction.

Jing-Yu Lee1, Hu-Hui Lee2.   

Abstract

In this study, we developed a new purification method using chondroitin sulfate C (CSC) and protamine sulfate (PS) to concentrate lentivirus. To evaluate the efficiency of this new method, we compared it with several previously described purification protocols, including virus concentrated by ultracentrifugation (Ultra), precipitated by polyethylene glycol (PEG), and sedimented by CSC combined with polybrene (PB). After using the different methods to purify and concentrate equivalent amounts of lentivirus supernatant, the virus pellets precipitated by the different methods were resuspended using the equivalent volumes of DMEM. Subsequently, 10 μl of each lentivirus stock carrying EGFP gene was used to transduce two types of cells, human embryonic kidney 293T (HEK293T) cells and mouse mesenchymal stem cells (mMSC). It was obvious that HEK293T and mMSC appeared much intensiver green fluorescence through virus transduction from PS method than from other methods. To quantitate the transduction efficiency of the viruses, we examined virus titer in the cells after transduction using a real-time PCR-based analysis. Accordingly, we verified that PS precipitation could generate virus with a higher titer (4.39 × 108 IU/ml) than PB (2.43 × 108 IU/ml), Ultra (1.16 × 108 IU/ml), and PEG (0.56 × 108 IU/ml) in HEK293T cells. As for HEK293T cells in mMSC, the PS method also generated virus with a higher titer (4.66 × 108 IU/ml) than the Ultra method (2.36 × 108 IU/ml), and a much higher titer than those of the other chemical-based precipitation methods using PB (4.82 × 106 IU/ml) and PEG (8.98 × 104 IU/ml). Furthermore, the HEK293T cells and mMSC transduced by PS(1X)-virus appeared to have higher cell growth ratios, respectively, than the HEK293T cells and mMSC transduced by lentivirus using the other methods. We conclude that our new method for purifying lentivirus is cost-effective, time-saving, and highly efficient, and that lentivirus purification by this means could possibly be used to transduce a variety of cells, including stem cells.

Entities:  

Keywords:  Concentration; Lentivirus; Protamine sulfate; Transduction

Year:  2017        PMID: 28884364      PMCID: PMC5809650          DOI: 10.1007/s10616-017-0133-0

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  27 in total

1.  A rapid method to produce high yields of purified rotavirus particles.

Authors:  Guillermo Adolfo Villegas; Marcelo Horacio Argüelles; Alejandro Andrés Castello; Neus Jiménez Mas; Graciela Glikmann
Journal:  J Virol Methods       Date:  2002-06       Impact factor: 2.014

2.  Simplified mammalian DNA isolation procedure.

Authors:  P W Laird; A Zijderveld; K Linders; M A Rudnicki; R Jaenisch; A Berns
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

3.  Production, purification and titration of a lentivirus-based vector for gene delivery purposes.

Authors:  Masoud Nasri; Ali Karimi; Mehdi Allahbakhshian Farsani
Journal:  Cytotechnology       Date:  2014-03-06       Impact factor: 2.058

4.  Engraftment of NOD/SCID mice with human CD34(+) cells transduced by concentrated oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein.

Authors:  J Gatlin; M W Melkus; A Padgett; P F Kelly; J V Garcia
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor.

Authors:  H Lee; J J Song; E Kim; C O Yun; J Choi; B Lee; J Kim; J W Chang; J H Kim
Journal:  Gene Ther       Date:  2001-02       Impact factor: 5.250

6.  Protamine-modified DDAB lipid vesicles promote gene transfer in the presence of serum.

Authors:  S Mizuarai; K Ono; J You; M Kamihira; S Iijima
Journal:  J Biochem       Date:  2001-01       Impact factor: 3.387

7.  Production and concentration of pseudotyped HIV-1-based gene transfer vectors.

Authors:  J Reiser
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

8.  Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities.

Authors:  Paul Lin; Yuan Lin; Donald P Lennon; Diego Correa; Mark Schluchter; Arnold I Caplan
Journal:  Stem Cells Transl Med       Date:  2012-11-29       Impact factor: 6.940

9.  A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow.

Authors:  Masoud Soleimani; Samad Nadri
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

10.  Efficient expansion of human keratinocyte stem/progenitor cells carrying a transgene with lentiviral vector.

Authors:  Daisuke Nanba; Natsuki Matsushita; Fujio Toki; Shigeki Higashiyama
Journal:  Stem Cell Res Ther       Date:  2013-10-18       Impact factor: 6.832

View more
  3 in total

1.  Assessment and streamlined preparation of low-cytotoxicity lentiviral vectors for mobilized human hematopoietic stem cell transduction.

Authors:  Paul T Toran; Martin Wohlfahrt; Julia Foye; Hans-Peter Kiem; Don M Wojchowski
Journal:  Exp Hematol       Date:  2020-05-27       Impact factor: 3.084

Review 2.  Lentiviral Vector Bioprocessing.

Authors:  Christopher Perry; Andrea C M E Rayat
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

3.  The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes.

Authors:  Sabina Sánchez-Hernández; Alejandra Gutierrez-Guerrero; Rocío Martín-Guerra; Marina Cortijo-Gutierrez; María Tristán-Manzano; Sandra Rodriguez-Perales; Laura Sanchez; Jose Luis Garcia-Perez; Jesus Chato-Astrain; Ricardo Fernandez-Valades; Ana Belén Carrillo-Galvez; Per Anderson; Rosa Montes; Pedro J Real; Francisco Martin; Karim Benabdellah
Journal:  Mol Ther Nucleic Acids       Date:  2018-08-18       Impact factor: 8.886

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.